EU Okays Bristol-Astra Diabetes Drug After US Rejection

Published November 15, 2012

EU okays Bristol-Astra diabetes drug after US rejection

Filed under: drug treatment news 2012

NEW YORK | Wed Nov 14, 2012 3:25pm EST … It is meant to be used in combination with other treatments for type 2 diabetes, including insulin, or as a standalone treatment for patients who cannot tolerate the widely used oral treatment metformin.
Read more on Reuters

Novartis heart failure drug cuts death by 37 percent: study

Filed under: drug treatment news 2012

LOS ANGELES | Tue Nov 6, 2012 8:54pm EST. LOS ANGELES (Reuters) – An experimental Novartis AG drug to treat hospitalized acute heart failure patients reduced deaths by 37 percent compared with a placebo and appeared to be safe, according to data from a …
Read more on Reuters

Patient treatment completed in pivotal trial evaluating Allon's davunetide

Filed under: drug treatment news 2012

13, 2012 /CNW/ – Allon Therapeutics Inc. (TSX: NPC) announced today that patient treatment has been completed in the multinational pivotal phase 2/3 clinical trial that is evaluating the Company's lead product davunetide as a potential treatment for …
Read more on Equities.com